17 Jan 2007 |
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
|
16 Jan 2007 |
4- Antibody AG Closes CHF 17 Million Series A Financing, Bringing the Total Series A Financing to CHF 23 Million ($ 18.5Million)
|
13 Jan 2007 |
BioInvent enters collaboration with Genentech to develop and commercialize BioInvent´s proprietary antibody for the potential treatment of cardiovascular diseases
|
12 Jan 2007 |
Immuno-Biological Laboratories Co., Ltd. and Intellect Neurosciences, Inc. Enter into Humanized Monoclonal Antibodies Development Agreement for the Treatment of Alzheimer's Disease
|
11 Jan 2007 |
Organon and the Academic Medical Center jointly develop novel treatment of rheumatoid arthritis
|
11 Jan 2007 |
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
|
10 Jan 2007 |
BioWa and Medarex Announce Allowance of Investigational New Drug Application for Second-Generation Anti-CD30 Antibody (MDX-1401) Enhanced Using Potelligent(TM) Technology
|
09 Jan 2007 |
Ablynx and Boehringer Ingelheim sign $265 million research and licensing agreement to develop new Alzheimer's treatments
|
09 Jan 2007 |
Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40
|
09 Jan 2007 |
Seattle Genetics to Present at the JPMorgan Annual Healthcare Conference
|
09 Jan 2007 |
Protherics submits DigiFab(TM) New Drug Submission in Canada
|
09 Jan 2007 |
Cytochroma Inc. and aOvaTechnologies, Inc., Sign License Agreement.
|
09 Jan 2007 |
Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCO Therapeutics
|
09 Jan 2007 |
Antibody-Company f-star Raises EUR1.5 Million in Seed Financing Round From Atlas Venture
|
06 Jan 2007 |
Helix BioPharma Corp. signs L-DOS47 manufacturing agreement with BioVectra dcl
|
06 Jan 2007 |
DSM Biologics and Crucell Announce PER.C6(R) Licensing Agreement with Biotecnol SA for Antibody Production
|
05 Jan 2007 |
Elusys Announces Collaborative Research And License Agreement With Pfizer
|
05 Jan 2007 |
Medarex Announces Enrollment Complete in Ipilimumab (MDX-010) Monotherapy Pivotal Registrational Trial for Metastatic Melanoma
|
05 Jan 2007 |
Raven Biotechnologies, Inc. And Wyeth (WYE) Partner To Evaluate And Develop
|
05 Jan 2007 |
Genentech Announces Positive Results from a Randomized Phase II Study of Pertuzumab in Combination with Gemcitabine for Advanced Ovarian Cancer
|
04 Jan 2007 |
MacroGenics and JDRF Form Partnership to Support Pivotal Phase II/III Clinical Trial of Anti-CD3 Monoclonal Antibody for Children and Adults With Recent-Onset Type 1 Diabetes
|
04 Jan 2007 |
Imclone Systems Commences Patient Treatment in U.S. Phase I Clinical Trial of IMC-3G3
|